Advisors Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.5M | Buy |
53,077
+13,212
| +33% | +$2.55M | 0.17% | 140 |
|
|
2025
Q4 | $7.33M | Buy |
39,865
+14,682
| +58% | +$2.57M | 0.12% | 206 |
|
|
2025
Q3 | $3.86M | Buy |
25,183
+4,227
| +20% | +$640K | 0.07% | 398 |
|
|
2025
Q2 | $2.93M | Sell |
20,956
-421
| -2% | -$59K | 0.05% | 470 |
|
|
2025
Q1 | $3.14M | Sell |
21,377
-181
| -0.8% | -$26.2K | 0.06% | 441 |
|
|
2024
Q4 | $2.82M | Sell |
21,558
-5,906
| -22% | -$827K | 0.05% | 475 |
|
|
2024
Q3 | $4.28M | Sell |
27,464
-537
| -2% | -$86.7K | 0.08% | 324 |
|
|
2024
Q2 | $4.37M | Sell |
28,001
-2,227
| -7% | -$335K | 0.09% | 304 |
|
|
2024
Q1 | $4.1M | Buy |
30,228
+1,916
| +7% | +$254K | 0.08% | 318 |
|
|
2023
Q4 | $3.81M | Buy |
28,312
+962
| +4% | +$125K | 0.08% | 322 |
|
|
2023
Q3 | $3.7M | Buy |
27,350
+1,871
| +7% | +$256K | 0.08% | 326 |
|
|
2023
Q2 | $3.65M | Sell |
25,479
-2,506
| -9% | -$369K | 0.07% | 328 |
|
|
2023
Q1 | $3.88M | Buy |
27,985
+1,533
| +6% | +$206K | 0.08% | 317 |
|
|
2022
Q4 | $3.59M | Buy |
26,452
+1,947
| +8% | +$244K | 0.07% | 330 |
|
|
2022
Q3 | $2.69M | Buy |
24,505
+351
| +1% | +$44.5K | 0.06% | 405 |
|
|
2022
Q2 | $3.19M | Sell |
24,154
-8,406
| -26% | -$1.1M | 0.06% | 355 |
|
|
2022
Q1 | $4.32M | Sell |
32,560
-5,130
| -14% | -$615K | 0.07% | 315 |
|
|
2021
Q4 | $4.39M | Sell |
37,690
-2,183
| -5% | -$257K | 0.06% | 339 |
|
|
2021
Q3 | $4.79M | Buy |
39,873
+7,494
| +23% | +$872K | 0.07% | 275 |
|
|
2021
Q2 | $3.88M | Buy |
32,379
+1,714
| +6% | +$188K | 0.06% | 343 |
|
|
2021
Q1 | $3.05M | Sell |
30,665
-4,078
| -12% | -$410K | 0.05% | 428 |
|
|
2020
Q4 | $3.47M | Sell |
34,743
-902
| -3% | -$95.5K | 0.06% | 343 |
|
|
2020
Q3 | $3.91M | Buy |
35,645
+2,659
| +8% | +$296K | 0.07% | 261 |
|
|
2020
Q2 | $3.49M | Sell |
32,986
-3,502
| -10% | -$362K | 0.07% | 290 |
|
|
2020
Q1 | $3.26M | Sell |
36,488
-3,437
| -9% | -$324K | 0.08% | 258 |
|
|
2019
Q4 | $3.98M | Sell |
39,925
-897
| -2% | -$84.4K | 0.07% | 311 |
|
|
2019
Q3 | $3.64M | Sell |
40,822
-314
| -0.8% | -$27.2K | 0.07% | 327 |
|
|
2019
Q2 | $3.4M | Buy |
41,136
+1,020
| +3% | +$80K | 0.06% | 369 |
|
|
2019
Q1 | $3.24M | Buy |
40,116
+5,647
| +16% | +$445K | 0.06% | 380 |
|
|
2018
Q4 | $2.62M | Sell |
34,469
-3,737
| -10% | -$292K | 0.05% | 416 |
|
|
2018
Q3 | $3.02M | Sell |
38,206
-3,872
| -9% | -$293K | 0.05% | 429 |
|
|
2018
Q2 | $2.96M | Sell |
42,078
-2,533
| -6% | -$182K | 0.05% | 459 |
|
|
2018
Q1 | $2.96M | Sell |
44,611
-1,841
| -4% | -$128K | 0.05% | 478 |
|
|
2017
Q4 | $3.22M | Sell |
46,452
-2,312
| -5% | -$156K | 0.05% | 459 |
|
|
2017
Q3 | $3.3M | Sell |
48,764
-2,553
| -5% | -$161K | 0.06% | 453 |
|
|
2017
Q2 | $3.5M | Sell |
51,317
-3,939
| -7% | -$257K | 0.06% | 434 |
|
|
2017
Q1 | $3.44M | Sell |
55,256
-7,238
| -12% | -$421K | 0.06% | 450 |
|
|
2016
Q4 | $3.42M | Sell |
62,494
-3,946
| -6% | -$224K | 0.06% | 459 |
|
|
2016
Q3 | $4.37M | Sell |
66,440
-4,223
| -6% | -$276K | 0.07% | 392 |
|
|
2016
Q2 | $4.27M | Sell |
70,663
-6,628
| -9% | -$385K | 0.07% | 404 |
|
|
2016
Q1 | $4.35M | Sell |
77,291
-7,604
| -9% | -$457K | 0.07% | 382 |
|
|
2015
Q4 | $5.76M | Sell |
84,895
-11,528
| -12% | -$756K | 0.09% | 314 |
|
|
2015
Q3 | $6.14M | Sell |
96,423
-14,377
| -13% | -$946K | 0.1% | 292 |
|
|
2015
Q2 | $7.06M | Sell |
110,800
-1,175
| -1% | -$80.4K | 0.1% | 282 |
|
|
2015
Q1 | $7.66M | Sell |
111,975
-41,539
| -27% | -$2.89M | 0.1% | 257 |
|
|
2014
Q4 | $10.8M | Sell |
153,514
-51,684
| -25% | -$3.7M | 0.14% | 184 |
|
|
2014
Q3 | $14.7M | Sell |
205,198
-51,643
| -20% | -$3.78M | 0.2% | 143 |
|
|
2014
Q2 | $19.1M | Sell |
256,841
-31,787
| -11% | -$2.3M | 0.26% | 97 |
|
|
2014
Q1 | $18.7M | Sell |
288,628
-13,260
| -4% | -$856K | 0.28% | 93 |
|
|
2013
Q4 | $17.9M | Buy |
301,888
+41,636
| +16% | +$2.26M | 0.29% | 95 |
|
|
2013
Q3 | $13.5M | Buy |
260,252
+28,883
| +12% | +$1.45M | 0.24% | 121 |
|
|
2013
Q2 | $10.9M | Buy |
+231,369
| New | +$11.8M | 0.21% | 148 |
|
Other funds holding AZN
IA
VCM
VAM
Advisors Asset Management's AZN Position: Q1 2026 in Review
Advisors Asset Management increased its AstraZeneca (AZN) stake by 33% in Q1 2026, buying an estimated $2.55M and bringing the position to 53,077 shares worth $10.5M. The position accounts for 0.17% of the portfolio, ranked #140.
Advisors Asset Management first reported a position in AZN in Q2 2013 and has held it in 52 quarters since. The position peaked at $19.1M in Q2 2014. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Advisors Asset Management held 53,077 shares of AstraZeneca worth $10.5M as of Q1 2026.
- Advisors Asset Management bought 13,212 AstraZeneca shares in Q1 2026, an estimated $2.55M.
- AstraZeneca made up 0.17% of Advisors Asset Management's portfolio in Q1 2026, its #140 holding.
- Advisors Asset Management first reported a position in AstraZeneca in Q2 2013 and has held it in 52 quarters since.
- Advisors Asset Management's AstraZeneca position peaked at $19.1M in Q2 2014.
- 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Advisors Asset Management's 13F filing for Q1 2026, filed 15 May 2026.